12:00 AM
 | 
Jun 25, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PRT064445: Phase I started

Portola began a U.S. Phase I trial to evaluate single ascending-doses of PRT4445 in about 40 healthy volunteers. The company said it also...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >